Gridelli, C <br/><br/>
Carboplatin + epirubicin +VP-16 + lenograstim followed by radiotherapy + carboplatin as radiosensitizer in limited small cell lung cancer. A multicenter phase II study.  [electronic resource] 

 -  Anticancer research   
 - 4179-83 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Multicenter Study 
<br/><br/><label>ISSN: </label>0250-7005 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Carboplatin--administration & dosage<br/>Carcinoma, Small Cell--drug therapy<br/>Combined Modality Therapy<br/>Epirubicin--administration & dosage<br/>Etoposide--administration & dosage<br/>Female<br/>Granulocyte Colony-Stimulating Factor--administration & dosage<br/>Humans<br/>Lenograstim<br/>Lung Neoplasms--drug therapy<br/>Male<br/>Middle Aged<br/>Radiation-Sensitizing Agents--administration & dosage<br/>Recombinant Proteins--administration & dosage